Ohio State University Comprehensive Cancer Center-COHORT 2 — Columbus, Ohio

Ohio State University Comprehensive Cancer Center-COHORT 2 is a clinical research site located in Columbus, Ohio, United States 43210.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Ohio State University Comprehensive Cancer Center-COHORT 2 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Grade I Neuroendocrine Carcinoma, Grade II Neuroendocrine Carcinoma, Grade III Neuroendocrine Carcinoma.

Sponsors: Dwight Owen.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ohio State University Comprehensive Cancer Center-COHORT 2?

Ohio State University Comprehensive Cancer Center-COHORT 2 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ohio State University Comprehensive Cancer Center-COHORT 2 conducted?

Ohio State University Comprehensive Cancer Center-COHORT 2 has 1 clinical trials on record, with 1 currently active. Their work covers Grade I Neuroendocrine Carcinoma, Grade II Neuroendocrine Carcinoma, Grade III Neuroendocrine Carcinoma.

Is Ohio State University Comprehensive Cancer Center-COHORT 2 accredited by Crixeo Health?

Ohio State University Comprehensive Cancer Center-COHORT 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ohio State University Comprehensive Cancer Center-COHORT 2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.